Surgery for high-risk locally advanced (pT3c) renal tumours: oncological outcomes and prognostic significance of a modified International Metastatic Renal Cell Cancer Database Consortium (IMDC) score.
Hannah R WarrenArchana FernandoKay ThomasConal AustinSimon ChowdhuryTim O'BrienPublished in: BJU international (2019)
A median survival of 29 months appears to justify this type of surgery. A prognostic model, the Guy's renal cancer score, using five readily available clinical measures, appears promising in patients with very-high-risk locally advanced tumours.
Keyphrases
- locally advanced
- rectal cancer
- squamous cell carcinoma
- papillary thyroid
- minimally invasive
- coronary artery bypass
- neoadjuvant chemotherapy
- squamous cell
- radiation therapy
- small cell lung cancer
- phase ii study
- emergency department
- lymph node metastasis
- single cell
- stem cells
- type diabetes
- prostate cancer
- adipose tissue
- childhood cancer
- metabolic syndrome
- robot assisted
- young adults
- coronary artery disease
- bone marrow
- adverse drug